LAVA Medtech Acquisition Corp. Class A Common Stock
LVAC
LVAC was delisted on the 10th of May, 2023.
54 hedge funds and large institutions have $116M invested in LAVA Medtech Acquisition Corp. Class A Common Stock in 2023 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 7 increasing their positions, 12 reducing their positions, and 7 closing their positions.
14% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 7
12% more capital invested
Capital invested by funds: $104M → $116M (+$12.4M)
2% more funds holding
Funds holding: 53 → 54 (+1)
42% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 12
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
QL
Quarry LP
New York
|
+$3.11M |
| 2 |
UOC
UBS O'Connor
Chicago,
Illinois
|
+$2.94M |
| 3 |
WCMNY
Westchester Capital Management (New York)
Valhalla,
New York
|
+$2.38M |
| 4 |
FTCM
First Trust Capital Management
Chicago,
Illinois
|
+$2.33M |
| 5 |
PC
Periscope Capital
Toronto,
Ontario, Canada
|
+$2.08M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SC
Sculptor Capital
New York
|
-$4.39M |
| 2 |
CCM
Context Capital Management
Lajolla,
California
|
-$2.31M |
| 3 |
Balyasny Asset Management
Chicago,
Illinois
|
-$776K |
| 4 |
SAMU
SONA Asset Management (US)
New York
|
-$611K |
| 5 |
WAM
Weiss Asset Management
Boston,
Massachusetts
|
-$514K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CS
51
Clear Street
New York
| $24K | +$23.8K | +2,300 | New |
|
52
Barclays
London,
United Kingdom
| $6.26K | – | – | – |
|
53
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| $5.99K | – | – | – |
|
|
TRCT
54
Tower Research Capital (TRC)
New York
| $2K | -$21 | -2 | -1% |
|
|
SC
55
Sculptor Capital
New York
| – | -$4.39M | -431,260 | Closed |
|
|
CCM
56
Context Capital Management
Lajolla,
California
| – | -$2.31M | -225,000 | Closed |
|
|
SAMU
57
SONA Asset Management (US)
New York
| – | -$611K | -60,000 | Closed |
|
|
WAM
58
Weiss Asset Management
Boston,
Massachusetts
| – | -$514K | -50,000 | Closed |
|
|
PP
59
Paloma Partners
Greenwich,
Connecticut
| – | -$414K | -40,000 | Closed |
|
60
AllianceBernstein
Nashville,
Tennessee
| – | -$183K | -17,920 | Closed |
|
61
CAPTRUST Financial Advisors
Raleigh,
North Carolina
| – | -$108K | -10,581 | Closed |
|
LVAC Hedge Fund Activity: Q1 2023 in Review
54 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in LAVA Medtech Acquisition Corp. Class A Common Stock (LVAC) for Q1 2023, worth a combined $116M — up 12% from $104M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new LVAC positions and 7 closed out — a net gain of 1 holder — while 7 added to existing stakes and 12 trimmed.
The largest buyer was Quarry LP, opening a new position worth an estimated $3.11M. The largest seller was Sculptor Capital, exiting entirely with an estimated $4.39M sold.
- 54 institutional investors held LAVA Medtech Acquisition Corp. Class A Common Stock (LVAC) as of Q1 2023, up from 53 in Q4 2022.
- Funds reported $116M of LAVA Medtech Acquisition Corp. Class A Common Stock stock for Q1 2023, up 12% quarter-over-quarter.
- 8 funds opened new LAVA Medtech Acquisition Corp. Class A Common Stock positions in Q1 2023 and 7 closed out, a net change of +1 holder.
- The largest LAVA Medtech Acquisition Corp. Class A Common Stock buyer in Q1 2023 was Quarry LP, an estimated $3.11M added.
- The largest LAVA Medtech Acquisition Corp. Class A Common Stock seller in Q1 2023 was Sculptor Capital, an estimated $4.39M sold.
Based on aggregated 13F filings for Q1 2023.